News

Media And Political Bulletin – 22 November 2018

Media and Political Bulletin

22 November 2018

Media Summary

Brexit — Doctors’ Demands

Politico, Helen Collis, 22 November 2018

Politico reports that as Brexit negotiators continue to debate the shape of the EU-U.K. future relationship, the British Medical Association will today join a group of pan-European health and professional organisations as they meet with EU negotiators to urge the continued mutual recognition of qualifications across the Continent after Brexit.

As Brexit looms, UK medicines agency head Hudson announces departure

PMLive, Andrew McConaghie, 21 November 2018

PMLive reports that Dr Ian Hudson, the long-serving head of the UK medicines regulator the MHRA, is to step down in September 2019.

The news adds to the huge upheaval at the agency, which faces huge uncertainty post-Brexit, with its future place within the European Medicines Agency (EMA) regulatory network still undecided.

Dr Hudson said: “My reasons for stepping down are both personal and professional. [..] I feel the time is right for a new person to guide the Agency and our work through its next phase, following the UK’s departure from the European Union next year.”

 

Parliamentary Coverage

Committee writes to Health Secretary about no deal preparations

The EU Home Affairs Sub-Committee has written to Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, asking for clarity on the Government’s contingency preparations to ensure the UK has continued access to medicines and medical products in the event of a ‘no deal’ Brexit.

 

Full Coverage

Brexit — Doctors’ Demands

Politico, Helen Collis, 22 November 2018

As Brexit negotiators continue to debate the shape of the EU-U.K. future relationship, the British Medical Association will today join a group of pan-European health and professional organisations as they meet with EU negotiators to urge the continued mutual recognition of qualifications across the Continent after Brexit.

As Brexit looms, UK medicines agency head Hudson announces departure

PMLive, Andrew McConaghie, 21 November 2018

Dr Ian Hudson, the long-serving head of the UK medicines regulator the MHRA, is to step down in September 2019.

The news adds to the huge upheaval at the agency, which faces huge uncertainty post-Brexit, with its future place within the European Medicines Agency (EMA) regulatory network still undecided.

The MHRA, like the pharma industry, has had to plan for all eventualities since the UK voted to leave the EU in June 2016.  This has included planning for a no deal Brexit, and it recently conducted a consultation on how it could re-position itself as a standalone regulator outside the EMA network with a ‘streamlined approach’.

However in the ‘soft Brexit’ as envisaged by Theresa May’s proposed deal, the MHRA would remain part of the EMA network, but wouldn’t having any voting rights or influence on decisions, and would still lose out on the lucrative work it has carried out for the EMA.

The financial impact of this is already affecting the agency, with the EMA reallocating work from the MHRA to other European agencies.

It’s against this background that Dr Hudson is resigning, and the timing of his departure means the MHRA will have to start looking for his successor in 2019, just as the pressure mounts before Brexit day on 29 March.

Dr Hudson said: “My reasons for stepping down are both personal and professional. I had always intended to reduce my total work commitment to enable me to pursue other things and perhaps have more of a portfolio career by the time I reached 60, which has now happened. I feel the time is right for a new person to guide the Agency and our work through its next phase, following the UK’s departure from the European Union next year.”

He added: “Although I will be standing down next autumn, my focus remains on ensuring the Agency delivers its essential contribution to public health, and I look forward to continuing to lead our work until September 2019.”

A paediatrician by training, Dr Hudson has been at the MHRA for 17 years, serving as its chief executive for the last five. He was promoted from his role as MHRA’s Licensing Director in 2013, where he was responsible for the majority of medicines licensing activities.

Media And Political Bulletin – 22 November 2018

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?